Zepp Health Net Change in Long-Term Investments 2017-2025 | ZEPP
Zepp Health net change in long-term investments from 2017 to 2025. Net change in long-term investments can be defined as the net cash flows from the sale and purchase of investments with maturities greater than one year.
| Zepp Health Annual Net Change in Long-Term Investments (Millions of US $) |
|
|---|---|
| 2024 | $-2 |
| 2023 | $4 |
| 2022 | $-1 |
| 2021 | $-165 |
| 2020 | $-15 |
| 2019 | $-12 |
| 2018 | $-30 |
| 2017 | $0 |
| 2016 | $-9 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.187B | $0.183B |
| Zepp Health Corp. developed a platform of proprietary technology including AI chips, biometric sensors and health data algorithms, which drive a broadening line of smart health products for consumers and analytics services for insurers, healthcare providers, employers, drug and treatment companies. Zepp Health Corp., formerly known as Huami Corporation, is based in CUPERTINO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.919B | 58.42 |
| Doximity (DOCS) | United States | $11.317B | 52.39 |
| Hims & Hers Health (HIMS) | United States | $10.654B | 110.70 |
| Tempus AI (TEM) | United States | $10.042B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.327B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.691B | 57.67 |
| Hinge Health (HNGE) | United States | $3.687B | 0.00 |
| Privia Health (PRVA) | United States | $2.458B | 168.00 |
| Schrodinger (SDGR) | United States | $1.674B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.583B | 0.00 |
| Phreesia (PHR) | United States | $1.580B | 0.00 |
| Enovis (ENOV) | United States | $1.502B | 8.38 |
| Azenta (AZTA) | United States | $1.434B | 66.64 |
| 10x Genomics (TXG) | United States | $1.421B | 0.00 |
| Omnicell (OMCL) | United States | $1.313B | 23.17 |
| Evolent Health (EVH) | United States | $1.146B | 97.60 |
| Claritev (CTEV) | United States | $0.705B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.540B | 0.00 |
| Veradigm (MDRX) | United States | $0.498B | 0.00 |
| Standard BioTools (LAB) | United States | $0.479B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.465B | 0.00 |
| Talkspace (TALK) | United States | $0.427B | 127.50 |
| TruBridge (TBRG) | United States | $0.337B | 746.67 |
| Outset Medical (OM) | United States | $0.310B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.270B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.269B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
| CapsoVision (CV) | United States | $0.206B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.160B | 0.00 |
| Pulmonx (LUNG) | United States | $0.128B | 0.00 |
| American Well (AMWL) | United States | $0.125B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.115B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.81 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.087B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.080B | 0.00 |
| 111 (YI) | China | $0.066B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.027B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |